The briefing
Researchers developing an Alzheimer’s therapy found that the same molecule occurs naturally in human blood at lower levels in cognitively impaired individuals. The team is now exploring the peptide as both a biomarker and a possible treatment, Medical Xpress reported.
Original headline
Search for Alzheimer's drug unexpectedly finds possible biomarker